Mechanistically, USP4 can directly bind to the TRAF domain to inhibit TRAF2/TRAF6 activity through deubiquitination in an activity-dependent manner and negatively regulate IL-1β and TNF-α-induced NF-κB activation, thereby inhibiting lung cancer metastasis (46). This evidence concerns the gene USP4 and lung carcinoma.